Dr. Giri is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
333 Cedar Street
New Haven, CT 06520
Summary
- Veda N. Giri, MD is Professor of Medicine at Yale University and is a medical oncologist with specialization in clinical cancer genetics. She serves as Division Chief of Clinical Cancer Genetics for Yale School of Medicine, Director of the Cancer Genetics and Prevention Program, and Director of the Early-Onset Cancer Program at Yale Cancer Center. As leader of Cancer Genetics and Prevention, Dr. Giri leads a comprehensive effort in genetic evaluation for precision medicine, tailored cancer screening, and hereditary cancer assessment across patient populations. She is the Principal Investigator of multiple grant-funded cancer genetic evaluation studies spanning genetic counseling, genetic testing, disparities, behavioral science, and implementation research. As Director of the Early-Onset Cancer Program, Dr. Giri is leading a cutting-edge translational effort to address clinical, research, and psychosocial needs of patients with early-onset cancers. Dr. Giri serves on several national committees including the National Comprehensive Cancer Network, NIH PDQ® Cancer Genetics Editorial Board, and American Society of Clinical Oncology, contributing expertise in cancer genetics at the national level.
Education & Training
- University of MichiganFellowship, Hematology and Medical Oncology, 2001 - 2004
- University of MichiganResidency, Internal Medicine, 1997 - 2000
- University of MichiganInternship, Internal Medicine, 1997 - 1998
- Sidney Kimmel Medical College at Thomas Jefferson UniversityClass of 1997
Certifications & Licensure
- CT State Medical License 2022 - 2025
- PA State Medical License 2004 - 2024
- NJ State Medical License 2017 - 2023
- DE State Medical License 2017 - 2019
- MI State Medical License 1999 - 2006
- American Board of Internal Medicine Medical Oncology
Awards, Honors, & Recognition
- Hobart Amory Hare Honor Medical Society Jefferson Medical College, 1996
- CMS Meaningful Use Stage 1 Certification EpicCare Ambulatory EMR, Epic Systems Corporation, 2013
Clinical Trials
- Technology-Enhanced Acceleration of Germline Evaluation for Therapy, TARGET Study Start of enrollment: 2020 Aug 27
- The Peer Genetic Study Start of enrollment: 2020 Jan 08
- Enhanced Genetic Awareness and Genetic Evaluation for Men Through Technology, ENGAGEMENT Study Start of enrollment: 2020 Jan 21
Roles: Contact
- Join now to see all
Publications & Presentations
PubMed
- Adaptation of the socioecological model to address disparities in engagement of Black men in prostate cancer genetic testing.Amy E Leader, Timothy R Rebbeck, William K Oh, Alpa V Patel, Eric P Winer
BMC Public Health. 2024-09-18 - 1 citationsBRCA1, BRCA2, and Associated Cancer Risks and Management for Male Patients: A Review.Heather H Cheng, Jeffrey W Shevach, Elena Castro, Fergus J Couch, Susan M Domchek
JAMA Oncology. 2024-09-01 - 4 citationsToward Informed Selection and Interpretation of Clinical Genomic Tests in Prostate Cancer.Gillian Vandekerkhove, Veda N Giri, Susan Halabi, Christopher McNair, Khaldoun Hamade
JCO Precision Oncology. 2024-03-01
Journal Articles
- Germline Genetic Testing for Inherited Prostate Cancer in Practice: Implications for Genetic Testing, Precision Therapy, and Cascade TestingColette Hyatt, William K Kelly, Veda N Giri, Leonard G Gomella, Karen E Knudsen, The Prostate
Press Mentions
- Dr. Veda Giri on Yale Cancer Answers: A Rise in Early Onset Cancers: What Does It Mean?October 28th, 2024
- Video May Aid in Precision Medicine for Prostate CancerOctober 13th, 2021
- Veda Giri, MD, on Genetic Testing in Prostate CancerOctober 21st, 2020
- Join now to see all
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence: